Richard Zou
@zou_richard
Pulmonary/CCM at @UPMCnews by way of @PACCSM_fellows, @PittICRE MSCR, @PittTweet alum x3, amateur barista, @dietcoke fanatic
ID: 470712663
22-01-2012 02:24:25
1,1K Tweet
863 Takipçi
669 Takip Edilen
Race-Neutral z-Score Classification of Airflow Obstruction: A Measured Step Forward American Thoracic Society (ATS) 🔓 Open Access 🔗 tinyurl.com/vz9437rm
Nick Mark MD To be clear, this is absolutely not correct. Academic centers will no longer be incentivized to support research, and thus fewer research positions will be available, making investigators inevitably turn to industry. This will end academic medicine and science as we know it.
Is this the end of rivaroxaban for acute VTE? Lana Castellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 56% reduction in bleeding risk with apixaban. A safer Rx with the same efficacy. #ISTH2025
Jeff Capel and Pitt Basketball are on fire. THREE top 100 recruits. Coach Capel and staff are two players away from a Fab 5. #H2P 🔵🔵🟡🟡